Welcome to the iCAD Investors Page

​iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.

The company's common stock is listed on the NASDAQ Stock Market under the symbol "ICAD".

Recent Press Releases

June 13, 2019
iCAD Introduces ProFound AI™ for 2D Mammography in Europe

June 13, 2019
iCAD Announces Pricing Of Public Offering Of Common Stock

June 12, 2019
iCAD Announces Proposed Public Offering Of Common Stock

May 7, 2019
iCAD Reports First Quarter 2019 Financial Result

May 6, 2019
iCAD Appoints R. Scott Areglado As Chief Financial Officer

May 1, 2019
iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7

LifeSci Advisors

Jeremy Feffer
917-749-1494

jeremy@lifesciadvisors.com

Media Inquiries

iCAD, Inc.
603.882.5200
pr@icadmed.com

iCAD is committed to corporate sustainability and to making a difference for our environment.

* See all Press Releases

Recent Events and Webcasts

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

​iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.